Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 18 recruiting now early-phase tilt

Eating Disorders: early-phase trial registry

18 of 38 indexed Eating Disorders trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #393 of 28,707 conditions by registered trial count.

38 US clinical trials · 18 currently recruiting · #393 of 28,707 conditions by registered trial count

Eating Disorders: 38 US clinical trials tracked, 18 recruiting.

Eating Disorders is the subject of 38 registered US clinical trials on ClinicalTrials.gov, 18 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Louisville, running 4 of these trials.

Enrollment posture brief

Registry condition eating-disorders

OPEN 18 | RECR 47% | LATE 1 | EARLY 3 | RANK #393 | SPON 4

Nearest open-share peer: Breast Cancer Stage I (47% recruiting · 19 trials)

Acute Leukemia55.3%Eating Disorders (this)47%Food Insecurity44.7%Back Pain31.6%Metastatic Pancreatic Adenoc28.9%
Open-enrollment share among volume-matched conditions near Eating Disorders

Eating Disorders lists 18 open slots (47% of 38 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Eating Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Eating Disorders is recruiting above its size-band peers.

    18 of 38 indexed trials (47.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Eating Disorders trials is spread across many organizations.

    University of Louisville accounts for 4 of 38 trials (10.5%). 23 distinct sponsors appear on at least one study for this condition label.

  3. Most Eating Disorders trials plan to enrol fewer than 100 people.

    Median target enrolment is 70 among the 38 trials that report a genuine target (sentinel values excluded). 23 of those (60.5%) plan for fewer than 100 participants.

  4. Eating Disorders research is mostly interventional.

    34 interventional and 4 observational studies make up this index (89.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 21Phase 41

Open and recent trials

38 total, page 1 of 1

RECRUITING 1,000 participants

Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study

Aura

NCT06664944

RECRUITING NA 320 participants

Innovations in Personalizing Treatment Study

University of Louisville

NCT06208605

RECRUITING NA 240 participants

Neurostimulation Versus Therapy for Problems With Emotions

Duke University

NCT05712057

RECRUITING NA 235 participants

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

Duke University

NCT05540704

RECRUITING NA 144 participants

Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)

University of Minnesota

NCT06631729

RECRUITING Phase 2 120 participants

The Role of Estrogen in the Neurobiology of Eating Disorders

Massachusetts General Hospital

NCT03740204

RECRUITING NA 100 participants

Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development

University at Albany

NCT07179068

RECRUITING NA 70 participants

Facing Eating Disorder Fears for Anorexia Nervosa

University of Louisville

NCT05596799

RECRUITING NA 70 participants

Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders

Milton S. Hershey Medical Center

NCT06085092

RECRUITING NA 60 participants

Targeting Social Function in Anxiety and Eating Disorders

University of Texas Southwestern Medical Center

NCT06198023

RECRUITING Early Phase 1 60 participants

Naltrexone Neuroimaging in Teens With Eating Disorders

Children's Mercy Hospital Kansas City

NCT05509257

RECRUITING NA 42 participants

Diabetes Body Project 2

Joslin Diabetes Center

NCT07468188

RECRUITING NA 30 participants

Exposure Therapy Study In Adults With Eating Disorders

Milton S. Hershey Medical Center

NCT06171711

RECRUITING Phase 1 30 participants

Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders

Auburn University

NCT06565637

RECRUITING NA 30 participants

Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders

Rogers Behavioral Health

NCT07017322

RECRUITING NA 26 participants

Relationships Between Exercise and Appetite in Women With Loss of Control Eating

Ohio University

NCT06602973

RECRUITING 25 participants

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

Denver Health and Hospital Authority

NCT06532734

RECRUITING NA 20 participants

Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

Milton S. Hershey Medical Center

NCT07237607

ACTIVE NOT RECRUITING NA 280 participants

Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

Oslo University Hospital

NCT05399446

ACTIVE NOT RECRUITING NA 77 participants

Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders

University of Pittsburgh

NCT05184556

ACTIVE NOT RECRUITING NA 60 participants

Preventing Disordered Eating and Body Dissatisfaction Among High-risk Pregnant Individuals

Massachusetts General Hospital

NCT06659354

ACTIVE NOT RECRUITING 50 participants

AN/BN Risk Factors Study

Stanford University

NCT05133037

COMPLETED NA 6,205 participants

Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations

Washington University School of Medicine

NCT04162847

COMPLETED NA 549 participants

Testing an Internet-Based Intervention for Preventing Eating Disorders

Stanford University

NCT00934583

COMPLETED NA 481 participants

Efficacy of the Female Athlete Body Project (FAB)

Pennington Biomedical Research Center

NCT01735994

COMPLETED NA 450 participants

Eating Disorder Prevention Programs

University of Texas at Austin

NCT00042185

COMPLETED NA 241 participants

Evaluating Body Acceptance Programs for Young Men

Auburn University

NCT05258409

COMPLETED NA 210 participants

Chatbot for Depression, Anxiety, and Eating Disorders

Dartmouth-Hitchcock Medical Center

NCT06013137

COMPLETED NA 205 participants

Treatment Uptake Chatbot for Eating Disorders

Washington University School of Medicine

NCT04806165

COMPLETED Phase 4 93 participants

Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa

New York State Psychiatric Institute

NCT00288574

COMPLETED NA 80 participants

Personalized Treatment for Eating Disorders Versus CBT-E Trial

University of Louisville

NCT05195840

COMPLETED NA 69 participants

The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention.

Stanford University

NCT05794763

COMPLETED NA 60 participants

Cognitive Therapy for Binge-Eating Disorder

University of North Carolina, Chapel Hill

NCT00050037

COMPLETED NA 59 participants

Personalized Treatment

University of Louisville

NCT04183894

COMPLETED NA 55 participants

Eating Disorder Prevention Program for Women With T1D

Stanford University

NCT05264376

COMPLETED NA 41 participants

Effectiveness of High Intensity Inpatient Versus Stepped Intensity Treatment for Anorexia Nervosa

New York State Psychiatric Institute

NCT00815815

COMPLETED 33 participants

Imaging the Dopamine Systems in Bulimia Nervosa

New York State Psychiatric Institute

NCT01493362

COMPLETED NA 10 participants

Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder

New York State Psychiatric Institute

NCT00320047

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Eating Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Diabetes Body Project Behavioral
2 trials
Placebo Drug
2 trials
Expressive Writing Control Condition Behavioral
1 trials
Healthy Weight Intervention Behavioral
1 trials
Dissonance Eating Disorder Prevention Program Behavioral
1 trials
Personalized Intervention Behavioral
1 trials
Brochure Other
1 trials
Healthy Weight Behavioral
1 trials

US sites by state

Facility locations filed on Eating Disorders trials. A trial with sites in several states counts in each.

California 7 trials
Pennsylvania 5 trials
New York 5 trials
Massachusetts 5 trials
Missouri 4 trials
Kentucky 4 trials
North Carolina 3 trials
Texas 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Eating Disorders page

38 registered trials, 18 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Eating Disorders condition card totals 38 registered trials; most-linked intervention Diabetes Body Project; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.